Drug Manufacturers - General Industry: Stock Analysis & Valuation

Industry: Drug Manufacturers - General | Sector: Healthcare

This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.

The Drug Manufacturers - General industry represents a focused group of companies with highly similar business models, competitive dynamics, and market forces. This granular view makes it easier to spot which companies have sustainable competitive advantages and which are likely overvalued or undervalued.

Your Industry Knowledge = Investment Edge

If you work in Drug Manufacturers - General, follow industry news, or understand the competitive landscape, you have a significant advantage over Wall Street analysts. Use this knowledge to evaluate which companies have durable moats, realistic growth prospects, and strong margins of safety.

Drug Manufacturers - General Stocks: Value Metrics

Review the stocks in this list to compare valuations, cash flow metrics, and value investing indicators. Look for companies trading below intrinsic value with sustainable competitive advantages.

Discounted stocks in the index
Company Current Price Current Price Discount
10 years
Enanta Pharmaceuticals
(ENTA)
$7.62 unknown
Theravance Biopharma
(TBPH)
$17.03 none
Atossa Therapeutics
(ATOS)
$1.59 none
Elanco Animal Health Incorporated
(ELAN)
$25.74 none
Rafael Holdings
(RFL)
$0.92 none
KalVista Pharmaceuticals
(KALV)
$27.00 none
Arrowhead Pharmaceuticals
(ARWR)
$41.37 none
Cumberland Pharmaceuticals
(CPIX)
$5.84 none
Edge Therapeutics
(EDGE)
$46.01 none
Alnylam Pharmaceuticals
(ALNY)
$143.82 unknown
Intra-Cellular Therapies
(ITCI)
$0.00 none
Ultragenyx Pharmaceutical
(RARE)
$17.22 none
Teva Pharmaceutical Industries Limited
(TEVA)
$38.54 11.0%
Xencor
(XNCR)
$34.01 none
Tonix Pharmaceuticals Holding Corp.
(TNXP)
$2.55 none
Supernus Pharmaceuticals
(SUPN)
$28.35 none
Rocket Pharmaceuticals
(RCKT)
$1.95 none
Vanda Pharmaceuticals
(VNDA)
$3.67 unknown
Corcept Therapeutics Incorporated
(CORT)
$64.98 none
Omeros Corporation
(OMER)
$13.21 none
Corbus Pharmaceuticals Holdings
(CRBP)
$2.06 none
Savara
(SVRA)
$4.26 none
Phibro Animal Health Corporation
(PAHC)
$33.29 none
Heron Therapeutics
(HRTX)
$0.25 none
TherapeuticsMD
(TXMD)
$1.71 none
Bristol-Myers Squibb Company
(BMY)
$58.80 none
Catalyst Pharmaceuticals
(CPRX)
$0.00 none
TG Therapeutics
(TGTX)
$63.34 none
Verrica Pharmaceuticals
(VRCA)
$2.74 none
Abeona Therapeutics
(ABEO)
$2.42 none
Ironwood Pharmaceuticals
(IRWD)
$4.70 unknown
Veru
(VERU)
$1.94 none
Johnson & Johnson
(JNJ)
$270.47 none
Perrigo Company plc
(PRGO)
$15.94 88.9%
China Pharma Holdings
(CPHI)
$0.44 unknown
Alkermes plc
(ALKS)
$44.94 none
Ocular Therapeutix
(OCUL)
$5.57 none
SIGA Technologies
(SIGA)
$2.40 80.4%
Axsome Therapeutics
(AXSM)
$129.36 none
Selecta Biosciences
(SELB)
$0.00 none
Ocuphire Pharma
(OCUP)
$0.00 none
LifeVantage Corporation
(LFVN)
$4.15 none
Regeneron Pharmaceuticals
(REGN)
$920.69 none
Ionis Pharmaceuticals
(IONS)
$26.58 none
Cara Therapeutics
(CARA)
$0.00 none
Jaguar Health
(JAGX)
$0.23 none
Inovio Pharmaceuticals
(INO)
$1.76 none
Collegium Pharmaceutical
(COLL)
$24.72 none
Aurinia Pharmaceuticals
(AUPH)
$14.70 none
Agios Pharmaceuticals
(AGIO)
$27.60 none
Viatris
(VTRS)
$19.63 none
SCYNEXIS
(SCYX)
$2.38 none
PTC Therapeutics
(PTCT)
$56.42 none
Zoetis
(ZTS)
$79.11 none
India Globalization Capital
(IGC)
$0.17 none
Sarepta Therapeutics
(SRPT)
$13.33 none
Innoviva
(INVA)
$18.41 none
Amicus Therapeutics
(FOLD)
$0.00 unknown
Evolus
(EOLS)
$6.52 none
Wave Life Sciences Ltd.
(WVE)
$2.56 none
Prestige Consumer Healthcare
(PBH)
$49.63 22.5%
Jazz Pharmaceuticals plc
(JAZZ)
$230.26 26.9%
Geron Corporation
(GERN)
$0.87 unknown
Galectin Therapeutics
(GALT)
$2.69 none
Viking Therapeutics
(VKTX)
$24.77 none
Puma Biotechnology
(PBYI)
$7.05 none
Amphastar Pharmaceuticals
(AMPH)
$28.25 none
Catalyst Biosciences
(CBIO)
$13.00 none
Esperion Therapeutics
(ESPR)
$0.00 none
United Therapeutics Corporation
(UTHR)
$554.73 none
BioMarin Pharmaceutical
(BMRN)
$60.41 none
AcelRx Pharmaceuticals
(ACRX)
$0.00 none
BeiGene, Ltd.
(BGNE)
$0.00 none
Nektar Therapeutics
(NKTR)
$30.20 unknown
XBiotech
(XBIT)
$1.73 none
Pfizer
(PFE)
$27.40 56.7%
Prothena Corporation plc
(PRTA)
$8.22 none
Immunic
(IMUX)
$6.99 none
AnaptysBio
(ANAB)
$46.63 none
Assertio Holdings
(ASRT)
$23.50 none
Abbott Laboratories
(ABT)
$103.00 none
Catalent
(CTLT)
$0.00 unknown
ARCA biopharma
(ABIO)
$0.00 none
Oncolytics Biotech
(ONCY)
$0.35 none
FibroGen
(FGEN)
$0.00 none
Lexicon Pharmaceuticals
(LXRX)
$1.53 unknown
Aptevo Therapeutics
(APVO)
$0.40 none
Akebia Therapeutics
(AKBA)
$0.39 none
Zai Lab Limited
(ZLAB)
$21.03 none
Northwest Biotherapeutics
(NWBO)
$0.13 none
Elite Pharmaceuticals
(ELTP)
$0.32 none
ANI Pharmaceuticals
(ANIP)
$68.55 none
NanoViricides
(NNVC)
$1.14 none
Pacira BioSciences
(PCRX)
$36.48 unknown
OPKO Health
(OPK)
$1.57 unknown
Rigel Pharmaceuticals
(RIGL)
$40.09 unknown

Industry-Level Investment Strategy

Industry analysis allows you to compare companies operating in nearly identical markets. This granularity reveals which businesses have true competitive advantages versus those merely benefiting from industry tailwinds.

Industry Leaders

Established companies with:

  • Strong brand recognition
  • Pricing power
  • Economies of scale
  • Distribution advantages
  • Customer loyalty

Often safer, but may trade at premium valuations

Niche Players

Specialists focusing on:

  • Specific market segments
  • Unique technologies
  • Geographic advantages
  • Specialized expertise
  • Customer relationships

Can offer excellent value if moat is strong

Emerging Competitors

Growth companies with:

  • Innovative business models
  • Technology advantages
  • Market share gains
  • Scalable platforms
  • Strong growth rates

Higher risk but potential for outsized returns

Key Questions for Drug Manufacturers - General Stocks

Competitive Analysis:

  • What creates customer switching costs?
  • How sustainable is the competitive moat?
  • Can new entrants easily disrupt the market?
  • What drives profitability differences?

Valuation Context:

  • How do P/E ratios compare within the industry?
  • Which companies generate superior returns?
  • Are dividends sustainable?
  • What's the realistic growth trajectory?